Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Phase 1, Open-label Study In Healthy Subjects To Investigate the Pharmacokinetics Of Pf-06412562 Following Single Oral Administration Of Modified Release Formulation In Fasted And Fed States

Next Previous
X
Search
Trial Profile

A Phase 1, Open-label Study In Healthy Subjects To Investigate the Pharmacokinetics Of Pf-06412562 Following Single Oral Administration Of Modified Release Formulation In Fasted And Fed States

Status: Completed
Phase of Trial: Phase I

Latest Information Update: 16 Nov 2015

Price :

$35 *

Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs PF 6412562 (Primary)
  • Indications Cognition disorders
  • Focus Pharmacokinetics
  • Sponsors Pfizer

    • Most Recent Events

    • 24 Nov 2014 According to the ClinicalTrials.gov record, status changed from recruiting to completed.
    • 06 Oct 2014 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.
    • 08 Sep 2014 Protocol has been amended to change in primary outcomes that resulted in change in the trial focus from pharmacokinetics and adverse reaction to only pharmacokinetics.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top